NCT00181155View on ClinicalTrials.gov

Intravenous Allopurinol in Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Congestive Heart Failure
Interventions
DRUG

Allopurinol

intravenous infusion of allopurinol (300mg)

DRUG

Placebo

intravenous infusion of 50 ml dose of 5% dextrose

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins University

OTHER

NCT00181155 - Intravenous Allopurinol in Heart Failure | Biotech Hunter | Biotech Hunter